[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 13, 1995

Informed Consent for Genetic Research on Stored Tissue Samples

Author Affiliations

From the Department of Pediatrics and School of Law, Vanderbilt University, Nashville, Tenn (Dr Clayton); the Molecular Biology Branch, Birth Defects and Genetic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Steinberg and Khoury); the National Center for Human Genome Research, Bethesda, Md (Ms Thomson): Chicago-Kent College of Law, Chicago, Ill (Ms Andrews); the National Breast Cancer Coalition, Washington, DC, and Virginia Breast Cancer Foundation, Richmond (Ms Kahn); Department of Medical Humanities, East Carolina University School of Medicine, Greenville, NC (Dr Kopelman); and the Alliance of Genetic Support Groups, Chevy Chase, Md (Ms Weiss).

JAMA. 1995;274(22):1786-1792. doi:10.1001/jama.1995.03530220052033
Abstract

Objective.  —To develop recommendations for obtaining adequate informed consent in the future when gathering tissue samples that may be used for genetic studies and defining the circumstances under which it is necessary to obtain further consent if tissue samples already in hand are to be used for such research.

Participants.  —Scientists, ethicists, lawyers, and consumers selected by the National Center for Human Genome Research and the Centers for Disease Control and Prevention to represent a wide array of opinions.

Evidence.  —Statutes, regulations, and cases and articles on law and ethics.

Consensus Process.  —Initial workshop, followed by circulation of several drafts of this document with opportunities for comment by workshop participants and others as well as smaller meetings involving participants with widely differing views.

Conclusions.  —Genetic research using stored tissue samples poses an array of benefits and risks to individuals, researchers, and society. As a result, the workshop participants conclude that (1) informed consent is required for all genetic research using linkable samples unless conditions for limitation or waiver are met; (2) informed consent is not required for genetic research using anonymous samples but may be considered if identifiers are to be removed from currently linkable samples; (3) institutional review boards could usefully review all protocols that propose to use samples for genetic research; and (4) further work regarding these issues is warranted.(JAMA. 1995;274:1786-1792)

×